GlassScriptPhysician profile
Nyein Tint
NPI 1336533447
$3,890.80
in general payments reported to CMS, 2019-2025
40 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $106 · 2021: $309 · 2022: $417 · 2023: $578 · 2024: $945 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,831.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,019.56 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $290.83 | 2019-2025 | Airsupra, Tezspire, Farxiga |
| Baxter Healthcare | $217.90 | 2024-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $201.06 | 2023-2025 | Dupixent |
| Mylan Specialty L.P. | $170.72 | 2023-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.01 | 2019-2024 | Ofev |
| Jazz Pharmaceuticals INC. | $147.83 | 2023-2024 | |
| United Therapeutics Corporation | $130.18 | 2024-2025 | Tyvaso |
| Grifols USA, LLC | $123.13 | 2021-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $119.91 | 2019-2022 | |
| Philips North America LLC | $118.05 | 2019-2025 | Encore, Respiratory, (8874) Incourage |
| Harmony Biosciences LLC | $100.76 | 2022-2025 | |
| Pfizer INC. | $91.55 | 2023-2025 | |
| Abbott Laboratories | $82.02 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $72.50 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $65.24 | 2023-2025 | Accrufer |
| Verona Pharma, INC. | $63.40 | 2025 | Ohtuvayre |
| Shionogi INC | $59.93 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $57.07 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $52.59 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lilly USA, LLC | $50.99 | 2025 | Mounjaro, Zepbound |
| Abbvie INC. | $44.90 | 2021-2025 | |
| Medtronic, INC. | $40.78 | 2025 | Symplicity G3 |
| Advanced Respiratory, INC | $38.15 | 2020 | |
| Genzyme Corporation | $38.15 | 2022-2023 | |
| Corcept Therapeutics | $37.65 | 2025 | Korlym |
| Beone Medicines USA, INC. | $35.69 | 2025 | Brukinsa |
| Merck Sharp & Dohme LLC | $29.47 | 2025 | Winrevair |
| Axsome Therapeutics, INC. | $29.43 | 2023 | Sunosi |
| Edwards Lifesciences Corporation | $25.62 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bard Peripheral Vascular, INC. | $25.40 | 2022 | |
| Avanir Pharmaceuticals, INC. | $23.35 | 2022 | |
| Viatris Specialty LLC | $21.93 | 2025 | Yupelri |
| Amgen INC. | $21.09 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.70 | 2021 | |
| Electromed, INC. | $16.32 | 2025 | Smartvest |
| Circassia INC. | $14.68 | 2019 | |
| Inogen, INC. | $14.63 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| E.R. Squibb & Sons, L.L.C. | $14.53 | 2022 | |
| Mallinckrodt Hospital Products INC. | $13.10 | 2023 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nyein Tint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.